Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
Completed · Phase 2
Conditions studied: Fever, Sweating, Hot Flashes, Infection, Neutropenia, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Antibiotics, such as daptomycin, may control neutropenia, fever, and infection in patients with cancer. PURPOSE: This phase II trial is studying how well daptomycin works in treating neutropenia and fever in patients with cancer.
Key facts
- Study ID
- NCT00335478
- Run by
- OHSU Knight Cancer Institute
- People needed
- 54
- Starts
- 2006-12-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2017-05-09
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- OHSU Knight Cancer Institute — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.